Literature DB >> 30628017

Glutamate Transporters: Expression and Function in Oligodendrocytes.

Edna Suárez-Pozos1, Elizabeth J Thomason1, Babette Fuss2.   

Abstract

Glutamate, the main excitatory neurotransmitter of the vertebrate central nervous system (CNS), is well known as a regulator of neuronal plasticity and neurodevelopment. Such glutamate function is thought to be mediated primarily by signaling through glutamate receptors. Thus, it requires a tight regulation of extracellular glutamate levels and a fine-tuned homeostasis that, when dysregulated, has been associated with a wide range of central pathologies including neuropsychiatric, neurodevelopmental, and neurodegenerative disorders. In the mammalian CNS, extracellular glutamate levels are controlled by a family of sodium-dependent glutamate transporters belonging to the solute carrier family 1 (SLC1) that are also referred to as excitatory amino acid transporters (EAATs). The presumed main function of EAATs has been best described in the context of synaptic transmission where EAATs expressed by astrocytes and neurons effectively regulate extracellular glutamate levels so that synapses can function independently. There is, however, increasing evidence that EAATs are expressed by cells other than astrocytes and neurons, and that they exhibit functions beyond glutamate clearance. In this review, we will focus on the expression and functions of EAATs in the myelinating cells of the CNS, oligodendrocytes. More specifically, we will discuss potential roles of oligodendrocyte-expressed EAATs in contributing to extracellular glutamate homeostasis, and in regulating oligodendrocyte maturation and CNS myelination by exerting signaling functions that have traditionally been associated with glutamate receptors. In addition, we will provide some examples for how dysregulation of oligodendrocyte-expressed EAATs may be involved in the pathophysiology of neurologic diseases.

Entities:  

Keywords:  Glutamate; Glutamate transporter; Multiple sclerosis; Myelination; Neuropsychiatric disorders; Oligodendrocyte

Mesh:

Substances:

Year:  2019        PMID: 30628017      PMCID: PMC6616022          DOI: 10.1007/s11064-018-02708-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  119 in total

1.  Cellular and regional expression of glutamate dehydrogenase in the rat nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry.

Authors:  A Schmitt; P Kugler
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Selective uptake of neuroactive amino acids by both oligodendrocytes and astrocytes in primary dissociated culture: a possible role for oligodendrocytes in neurotransmitter metabolism.

Authors:  R Reynolds; N Herschkowitz
Journal:  Brain Res       Date:  1986-04-23       Impact factor: 3.252

Review 3.  Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.

Authors:  Ileana Micu; Jason R Plemel; Andrew V Caprariello; Klaus-Armin Nave; Peter K Stys
Journal:  Nat Rev Neurosci       Date:  2017-11-09       Impact factor: 34.870

4.  Expression of glutamate transporters in rat optic nerve oligodendrocytes.

Authors:  M Domercq; M V Sánchez-Gómez; P Areso; C Matute
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

5.  Vesicular release of glutamate from unmyelinated axons in white matter.

Authors:  Jennifer L Ziskin; Akiko Nishiyama; Maria Rubio; Masahiro Fukaya; Dwight E Bergles
Journal:  Nat Neurosci       Date:  2007-02-11       Impact factor: 24.884

6.  Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.

Authors:  David Pitt; Iris E Nagelmeier; Heather C Wilson; Cedric S Raine
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

Review 7.  On Myelinated Axon Plasticity and Neuronal Circuit Formation and Function.

Authors:  Rafael G Almeida; David A Lyons
Journal:  J Neurosci       Date:  2017-10-18       Impact factor: 6.167

8.  Neuronal activity biases axon selection for myelination in vivo.

Authors:  Jacob H Hines; Andrew M Ravanelli; Rani Schwindt; Ethan K Scott; Bruce Appel
Journal:  Nat Neurosci       Date:  2015-04-06       Impact factor: 24.884

Review 9.  Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia.

Authors:  D A Maas; A Vallès; G J M Martens
Journal:  Transl Psychiatry       Date:  2017-07-18       Impact factor: 6.222

Review 10.  Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.

Authors:  Juliana Silva Cassoli; Paul C Guest; Berend Malchow; Andrea Schmitt; Peter Falkai; Daniel Martins-de-Souza
Journal:  NPJ Schizophr       Date:  2015-09-23
View more
  8 in total

Review 1.  The oligodendrocyte growth cone and its actin cytoskeleton: A fundamental element for progenitor cell migration and CNS myelination.

Authors:  Elizabeth J Thomason; Miguel Escalante; Donna J Osterhout; Babette Fuss
Journal:  Glia       Date:  2019-11-07       Impact factor: 7.452

Review 2.  Sodium-Calcium Exchangers of the SLC8 Family in Oligodendrocytes: Functional Properties in Health and Disease.

Authors:  Samantha A Spencer; Edna Suárez-Pozos; Miguel Escalante; Yu Par Myo; Babette Fuss
Journal:  Neurochem Res       Date:  2020-01-11       Impact factor: 3.996

3.  Estimating the glutamate transporter surface density in distinct sub-cellular compartments of mouse hippocampal astrocytes.

Authors:  Anca R Rǎdulescu; Gabrielle C Todd; Cassandra L Williams; Benjamin A Bennink; Alex A Lemus; Haley E Chesbro; Justin R Bourgeois; Ashley M Kopec; Damian G Zuloaga; Annalisa Scimemi
Journal:  PLoS Comput Biol       Date:  2022-02-04       Impact factor: 4.475

Review 4.  Recent Investigations on Neurotransmitters' Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies-Glia Dynamics in Stem Cell Therapy.

Authors:  Narasimha M Beeraka; P R Hemanth Vikram; M V Greeshma; Chinnappa A Uthaiah; Tahani Huria; Junqi Liu; Pramod Kumar; Vladimir N Nikolenko; Kirill V Bulygin; Mikhail Y Sinelnikov; Olga Sukocheva; Ruitai Fan
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

Review 5.  New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?

Authors:  Giuseppe Scalabrino
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

6.  Deletion of the Sodium-Dependent Glutamate Transporter GLT-1 in Maturing Oligodendrocytes Attenuates Myelination of Callosal Axons During a Postnatal Phase of Central Nervous System Development.

Authors:  Elizabeth J Thomason; Edna Suárez-Pozos; Fatemah S Afshari; Paul A Rosenberg; Jeffrey L Dupree; Babette Fuss
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

7.  The Expression of GLAST and GLT1 in a Transient Cerebral Ischemia Mongolian Gerbil Model.

Authors:  Yanling Shen; Huiling Lu; Runnan Xu; Haibo Tian; Xuewei Xia; Fiona H Zhou; Liping Wang; Jianghui Dong; Liyuan Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-23       Impact factor: 2.570

8.  Transient astrocyte-like NG2 glia subpopulation emerges solely following permanent brain ischemia.

Authors:  Denisa Kirdajova; Lukas Valihrach; Martin Valny; Jan Kriska; Daniela Krocianova; Sarka Benesova; Pavel Abaffy; Daniel Zucha; Ruslan Klassen; Denisa Kolenicova; Pavel Honsa; Mikael Kubista; Miroslava Anderova
Journal:  Glia       Date:  2021-07-27       Impact factor: 8.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.